Financials
- Market Capitalization 157.6336 M
- Employee 184
- Founded 2004
- CEO Laura Niklason
- Website www.humacyte.com
- Headquarter Delaware, United States
- FIGI BBG00XPPT7S7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.36
Relación precio/flujo de caja
7.27
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 7153 | SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0150 USD | +20.00% | -37.50% | +13.64% | -70.00% | 275.27 M USD | ||
| 7181 | SRZNW Surrozen, Inc. - Warrant | 0.0128 USD | 0.00% | +33.33% | -23.81% | -28.49% | 254.03 M USD | ||
| 7276 | YDESW YD Bio Limited - Warrants | 0.2600 USD | +1.52% | -21.26% | -18.75% | -52.73% | 150.07 M USD | ||
| 7285 | FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 18.75 USD | +0.27% | -5.73% | -10.71% | +134.38% | 136.69 M USD |